Patient monitoring equipment developer and supplier LiDCO Group says that first quarter trading was better than expected.
This will help to underpin forecasts that the loss will almost halve to £1.1m this year.
Revenues were 38% higher with the US revenues 69% higher. This is due to the success of the high usage programme with more contracts added this year. Recurring revenues were 42% ahead.
There was strong growth from distributors, but this appears to be a question of timing and is unlikely to be replicated.
The share price had been trading at around its low, but the positive news helped it rise by one-quarter to 5p. There should be £1.2m in the ban at the end of January 2020.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
CEPS is selling its investment in the CEM group.
Food ingredients supplier Real Good Food is showing some signs of improvement but there is a long way to go.
Better news from telecoms hardware supplier Filtronic, which is trading in line with expectations.